• sales@syndicatedanalytics.com
  • +1-213-316-7435

Antibody Drug Conjugates Market: Global Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast, 2018-2023



“Antibody Drug Conjugates Market: Global Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast, 2018-2023” provides a deep and thorough evaluation of the antibody drug conjugates market by drugs (adcetris, kadcyla); by mechanism of action (LgG1 antibodies, HER2 antibodies); by technology used ADCs (SGEN, IMGN, IMMU, Others); by application (breast cancer, lymphoma); and by geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa). The report also analyses the competitive structure of the antibody drug conjugates industry and provides the profiles of major players operating in the market. Some of these include Agensys., Immunogen, Immunomedics, Inc., Seattle Genetics Inc., Genentech Inc.

Beginning with a global overview, the report explores the dynamics that have a strong influence on the antibody drug conjugates market and can also impact its future growth. Taking 2018 as the base year, the report covers historical market scenario from 2010-2017 and provides forecasts till 2023. This includes the study of value and volume trends and pricing history. Growth inducing factors, market restraints and recent developments have also been analysed in the report in order to provide deeper knowledge about the industry. On a regional basis, the report examines the antibody drug conjugates market in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. For each of these regions, the report studies the antibody drug conjugates market in detail for latest trends, outlook and opportunities. 

Antibody Drug Conjugates Market

Antibody Drug Conjugates Market Key Segments:

Segmentation by Drugs:

  • Adcetris
  • Kadcyla

Segmentation by Mechanism of Action:

  • LgG1 antibodies
  • HER2 Antibodies

Segmentation by Application:

  • Breast Cancer
  • Lymphoma

Segmentation by Technology used ADCs 

  • SGEN
  • IMGN
  • IMMU
  • Others

 Segmentation by Region:

  • Asia-Pacific
  • Europe
  • Latin America
  • North America
  • Middle East & Africa

Competitive Landscape:

  • Agensys
  • Immunogen
  • Immunomedics, Inc
  • Seattle Genetics Inc.
  • Genentech Inc.

The price margins for the products along with the various success and risk factors for manufacturers have also been covered in the report. Moreover, in order to determine market attractiveness, the report analyses the antibody drug conjugates industry along the parameters of the porter’s five forces model. This model examines the degree of competition in the antibody drug conjugates industry by analysing the threat posed by new entrants and substitutes, and the bargaining power of suppliers and buyers. Swot analysis of the market has also been presented in the report which highlights the strengths, weaknesses, opportunities and threats pertaining to the antibody drug conjugates industry. Furthermore, the value chain analysis of the antibody drug conjugates industry has also been covered in the report. This comprises of all the activities in the value chain, such as the procurement of various raw materials, manufacturing and sales of the products, and their distribution.

Highlights of The Antibody Drug Conjugates Market

  • Historical and current scenario
  • Trends and developments
  • Market forecast
  • Price analysis and forecast
  • Porter’s five forces analysis
  • SWOT analysis
  • Value chain analysis

The report is a result of exhaustive primary and secondary research undertaken by analysts having years of experience in the antibody drug conjugates industry. All the qualitative and quantitative aspects of the industry have been covered and the collected data has been analysed and presented in the form of easily comprehensible charts, graphs and tables.

1 Introduction 
    1.1 Research Objectives 
    1.2 Stakeholders
    1.3 Scope of the Report
    1.4 Assumptions and Limitations
2. Research Methodology 
    2.1. Data Collection
       2.1.1 Primary Sources
       2.1.2 Secondary Sources
    2.2 Market Size Estimation
        2.2.1 Bottom-Up Approach
        2.2.2 Top-Down Approach
    2.3 Data Validation
3. Executive Summary
4. Global Antibody Drug Conjugates Market

     4.1 Industry Overview
     4.2 Key Industry Developments
     4.3 Market Trends
        4.3.1 Key Market Indicators
        4.3.2 Historical Market Trends
        4.3.3 Market Forecast
     4.4 Price Analysis
        4.4.1 Key Price Indicators
        4.4.2 Pricing Structure
        4.4.3 Historical Price Trends
        4.4.4 Price Forecast
     4.5 Market Breakup By Region
     4.6 Market Breakup By Drugs
     4.7 Market Breakup By Mechanism of Action
     4.8 Market Breakup By Application
     4.9 Market Breakup By Technology used ADCs
5. Global Antibody Drug Conjugates Market: Value Chain Analysis
     5.1 Overview
     5.2 Research and Development
     5.3 Raw Material Suppliers
     5.4 Inbound Logistics
     5.5 Production
     5.6 Marketing 
     5.7 Outbound Logistics
     5.8 Consumers 
6. Global Antibody Drug Conjugates Market: SWOT Analysis
     6.1 Overview
     6.2 Strengths
     6.3 Weaknesses
     6.4 Opportunities
     6.5 Threats
7. Global Antibody Drug Conjugates Market: Porter’s Five Forces Analysis
     7.1 Overview
     7.2 Threat of New Entrants
     7.3 Threat of Substitutes
     7.4 Bargaining Power of Buyers
     7.5 Bargaining Power of Suppliers
     7.6 Intensity of Rivalry
8.  Competitive Landscape
     8.1 Market Structure
     8.2 Key Players 
     8.3 Key Success Factors 
9. Performance By Region
     9.1 North America
         9.1.1 Overview
         9.1.2 Market Trends
         9.1.3 Market Segmentation
         9.1.4 Market Forecast
     9.2 Europe
         9.2.1 Overview
         9.2.2 Market Trends
         9.2.3 Market Segmentation
         9.2.4 Market Forecast
     9.3 Asia Pacific 
        9.3.1 Overview
        9.3.2 Market Trends
        9.3.3 Market Segmentation
        9.3.4 Market Forecast
     9.4 Latin America
        9.4.1 Overview
        9.4.2 Market Trends
        9.4.3 Market Segmentation
        9.4.4 Market Forecast
     9.5 Middle East and Africa
        9.5.1 Overview
       9.5.2 Market Trends
       9.5.3 Market Segmentation
       9.5.4 Market Forecast
10 Key Player Profiles


List of Figures
    
Figure 1: Global: Antibody Drug Conjugates Market, 2010 - 2017
Figure 2: Global: Antibody Drug Conjugates Market Forecast, 2018 - 2023
Figure 3: Global: Antibody Drug Conjugates Market: Price Trends, 20010 - 2017
Figure 4: Global: Antibody Drug Conjugates Market Forecast: Price Trends, 2018 - 2023
Figure 5: Global: Antibody Drug Conjugates Market: Breakup by Region, 2017
Figure 6: Global: Antibody Drug Conjugates Market: Breakup by Drugs, 2017
Figure 7: Global: Antibody Drug Conjugates Market: Breakup by Mechanism of Action, 2017
Figure 8: Global: Antibody Drug Conjugates Market: Breakup by Application, 2017
Figure 9: Global: Antibody Drug Conjugates Market: Breakup by Technology used ADCs, 2017
Figure 10: Global: Antibody Drug Conjugates Industry: Value Chain Analysis
Figure 11: Global: Antibody Drug Conjugates Industry: SWOT Analysis
Figure 12: Global: Antibody Drug Conjugates Industry: Porter’s Five Forces Analysis
Figure 13: Global: Antibody Drug Conjugates Market: Breakup by Key Players, 2017
Figure 14: North America: Antibody Drug Conjugates Market, 2010-2017
Figure 15: North America: Antibody Drug Conjugates Market: Breakup by Segment, 2018
Figure 16: North America: Antibody Drug Conjugates Market Forecast, 2018-2023
Figure 17: Europe: Antibody Drug Conjugates Market, 2010-2017
Figure 18: Europe: Antibody Drug Conjugates Market: Breakup by Segment, 2017
Figure 19: Europe: Antibody Drug Conjugates Market Forecast, 2018-2023
Figure 20: Asia Pacific: Antibody Drug Conjugates Market, 2010-2017
Figure 21: Asia Pacific: Antibody Drug Conjugates Market: Breakup by Segment, 2017
Figure 22: Asia Pacific: Antibody Drug Conjugates Market Forecast, 2018-2023
Figure 23: Latin America: Antibody Drug Conjugates Market, 2010-2017
Figure 24: Latin America: Antibody Drug Conjugates Market: Breakup by Segment, 2017
Figure 25: Latin America: Antibody Drug Conjugates Market Forecast, 2018-2023
Figure 26: Middle East and Africa: Antibody Drug Conjugates Market, 2010-2017
Figure 27: Middle East and Africa: Antibody Drug Conjugates Market: Breakup by Segment, 2017
Figure 28: Middle East and Africa: Antibody Drug Conjugates Market Forecast, 2018-2023


List of Tables

Table 1: Global: Antibody Drug Conjugates Industry: Market Summary    
Table 2: Global: Antibody Drug Conjugates Industry: Market Overview, 2017 and 2023
Table 3: Global: Antibody Drug Conjugates Industry: Market Structure    
Table 4: Global: Antibody Drug Conjugates Market: Market by Region, 2018-2023    
 

Special Prices


    Syndicated Analytics provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations

  • For more information, feel free to contact us.





Related Reports

Garbage Bags Prefeasibility Analysis Report 2019

The report offers an in-depth roadmap or setting up a Garbage Bags manufacturing plant covering the essential techno-commercial aspects

Sanitary Napkins Prefeasibility Analysis Report 2019

The report offers an in-depth roadmap or setting up a Sanitary Napkins manufacturing plant covering the essential techno-commercial aspects.

Surgical Gloves Prefeasibility Analysis Report 2019

The report offers an in-depth roadmap or setting up a Surgical Gloves manufacturing plant covering the essential techno-commercial aspects

Linear Alkylbenzene Sulfonate Production Cost Analysis Report 2019

This production cost analysis report by Syndicated Analytics is the result of comprehensive examination of the Linear Alkylbenzene Sulfonate manufacturing process

GCC Healthcare Information Software Market by Development (On-Premise and Cloud) and Application (Hospitals, Clinics, Medical Research Centers and others):Industry Analysis, Trends, Growth and Forecast 2019-2024

The GCC Healthcare Information Software Market was worth US$ XX Billion in 2018, expanding at a CAGR of X% during 2011-2018. The market is projected to register a CAGR of X% during 2019-2024, reaching US$ XX Billion by 2024.